Skip to main content
Cancer Medicine logoLink to Cancer Medicine
. 2019 Feb 21;8(4):1652–1654. doi: 10.1002/cam4.2011

Human cancer, the naked mole rat and faunal turnovers

Anders Bredberg 1,, Birger Schmitz 2
PMCID: PMC6488205  PMID: 30790458

Abstract

We argue that the human evolutionary heritage with frequent adaptations through geological time to environmental change has affected a trade‐off between offspring variability and cancer resistance, and thus favored cancer‐prone individuals. We turn the attention to a factor setting the highly cancer‐resistant naked mole rat apart from most other mammals: it has remained phenotypically largely unchanged since 30‐50 million years ago. Research focusing on DNA stability mechanisms in ‘living fossil’ animals may help us find tools for cancer prevention and treatment.

Keywords: cancer resistance, Cretaceous‐Paleogene boundary, Heterocephalus glaber, human cancer excess, human mutation rate, naked mole rat, Peto's paradox, rapid human evolution

1.

We put to the test a hypothesis that much of human cancer is a consequence of our evolutionary heritage, with a high level of genetic variation during periods with rapid species radiation. In the trade‐off between benefit from offspring variability and deleterious effects of most new mutations, the more cancer‐prone individuals are then favored. To the best of our knowledge, this has not been discussed earlier in the medical literature, although the existence of a similar trade‐off has been suggested by for example, Fisher in 19301.

The Heterocephalus glaber naked mole rat (NMR) has been extensively studied because of its long life span and extremely low cancer incidence.2, 3, 4 Interestingly, the NMR genome has features suggesting a high level of genetic stability; for example, there has been only little of rearrangement, including a low number of transposons (25%; humans have 40%).3 A recent long‐term study found that the mortality rate does not increase with age, and interpreted this to indicate that NMR is a nonaging mammal,5 supporting that NMR somatic cells are genetically highly stable. We wish to turn the attention to a factor setting NMR apart from most other mammals which, to the best of our knowledge, has not been focused upon: it is a bona fide “living fossil” phenotypically largely unchanged since 30‐50 million years ago (Ma).3, 6, 7, 8 This remarkable persistence over time may be causally linked to a peculiar lifestyle; NMR lives strictly underground excluding it from competition with other mammals, being especially relevant during periods of sudden climate change. Other species with an underground habitat are not fully sheltered from such competition because they spend some time in open air. Thus, the NMR may not have participated in the filling of open niches, which is a process associated with genetic instability; for example, there is evidence of a 10‐fold elevated DNA base substitution rate during the first 400 000 years of large‐scale mammalian diversification following the Chicxulub asteroid impact 66 Ma and Cretaceous‐Paleogene mass extinction.9, 10 In this respect, NMR differs not least with humans which originated much later, with whole genome sequencing data suggesting unanticipated and significant adaptive changes repeatedly until as late as the last couple of 1000 years.11, 12, 13

It is often suggested that we can learn from evolution why the modern and affluent lifestyle of humans comes with a high disease burden, and also how a fix for cancer has already been invented by other animals.14, 15, 16, 17 There has been evolution of a just‐right for each species set of energy‐demanding homeostasis mechanisms serving the individual to stay fit, and which increases in complexity with body size and life span. One cancer‐modulating homeostasis mechanism subject to natural selection may be the basal cellular mutation rate.

There has probably been selection of both promutagenic and DNA‐protective genes, in both somatic and germ cells.18 The mutation rate is dynamic and varies among primates,19 with the spectrum of mutation types having changed in humans during as short an evolutionary time as the last 20 000 years (serving as another indicator that there has recently been extensive human genetic change).12, 20 Genetic variability in somatic cells is adjustable even within a human individual.21 Because it is likely that the same set of DNA stability genes is operating in both somatic and germ cells,18, 22 and because cancer has its roots in mutated somatic cells, it is conceivable that selection for germ cell genetic variability will lead to more of cancer.

It should be possible to test our hypothesis by assessing the germ‐line mutation rate in NMR captivity populations2, 5 with modern methods.20, 21, 23, 24, 25 A finding of a relatively low mutation rate as compared with humans and other mammals would be an indication that a heavy load of recent species radiations has left a genetic scar affecting most mammals of today. Also, an investigation of other “living fossils” such as the duck‐billed platypus mammal, the coelacanth lungfish, and the crocodile and tuatara reptiles, may possibly be informative. Although data on cancer incidence in wild animals are sparse, there have been occasional case reports on tumors in some of these “living fossils”26, 27, 28, 29, 30 compatible with a cancer incidence as low as in NMR. Conversely, it may be informative to determine the mutation rate also in domestic animals, for which cancer seems to be a common disease and where breeding may have selected for offspring variability.31, 32

In conclusion, we argue that the human evolutionary heritage with many relatively recent species radiations and within‐species adaptations has affected a trade‐off between offspring variability and cancer resistance. If our hypothesis can be verified, research focusing on DNA stability may help us learn from cancer‐resistant animals and find tools for cancer prevention and treatment.

CONFLICT OF INTEREST

There is no conflict of interest.

Bredberg A, Schmitz B. Human cancer, the naked mole rat and faunal turnovers. Cancer Med. 2019;8:1652–1654. 10.1002/cam4.2011

Both authors conceived and wrote the article.

REFERENCES

  • 1. Bodmer WB. Cancer and evolution. Isr J Ecol Evol. 2006;52:233‐245. [Google Scholar]
  • 2. Edrey YH, Hanes M, Pinto M, Mele J, Buffenstein R. Successful aging and sustained good health in the naked mole rat: a long‐lived mammalian model for biogerontology and biomedical research. ILAR J. 2011;52:41‐53. [DOI] [PubMed] [Google Scholar]
  • 3. Kim EB, Fang X, Fushan AA, et al. Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature. 2011;479:223‐227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Delaney MA, Ward JM, Walsh TF, et al. Initial case reports of cancer in naked mole‐rats (Heterocephalus glaber). Vet Pathol. 2016;53:691‐696. [DOI] [PubMed] [Google Scholar]
  • 5. Ruby JG, Smith M, Buffenstein R. Naked mole rat mortality rates defy Gompertzian laws by not increasing with age. eLife. 2018;7:31157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Van Daele PAAG, Faulkes CG, Verheyen E, Adriaens D. African mole‐rats (Bathyergidae): a complex radiation in tropical soils In: Begall S, Burda H, Schleich CE, eds. Subterranean rodents: news from underground. Berlin: Springer; 2007. [Google Scholar]
  • 7. Patterson BD, Upham NS. A newly recognized family from the Horn of Africa, the Heterocephalidae (Rodentia: Ctenohystrica). Zool J Linnean Soc. 2014;172:942. [Google Scholar]
  • 8. Wilson DE, Lacher TE Jr, Mittermeier RA (eds.) Handbook of the mammals of the world, Volume 6, Lagomorphs and rodents I. Barcelona: Lynx Publisher; 2016. [Google Scholar]
  • 9. O'Leary MA, Bloch JI, Flynn JJ, et al. Response to comment on “The placental mammal ancestor and the post‐K‐Pg radiation of placentals”. Science. 2013;341(6146):613. [DOI] [PubMed] [Google Scholar]
  • 10. Halliday TJD, Upchurch P, Goswami A. Eutherians experienced elevated evolutionary rates in the immediate aftermath of the Cretaceous-Palaeogene mass extinction. Proc Royal Soc B. 2016;283:20153026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Scheinfeldt LB, Tishkoff SA. Recent human adaptation: genomic approaches, interpretation and insights. Nat Rev Genet. 2013;14:692‐702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Harris K, Pritchard JK. Rapid evolution of the human mutation spectrum. eLife. 2017;6:e24284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Scally A. Global clues to the nature of genomic mutations in humans. An analysis of worldwide human genetic variation reveals the footprints of ancient changes in genomic mutation processes. eLife. 2017;6:e27605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Bredberg A. Cancer: more of polygenic disease and less of multiple mutations? A quantitative view‐point Cancer (American Cancer Society). 2011;117:440‐445. [DOI] [PubMed] [Google Scholar]
  • 15. Caulin AF, Maley CC. Peto's paradox: evolution's prescription for cancer prevention. Trends Ecol Evol. 2011;26:175‐182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Greaves M. Evolutionary determinants of cancer. Cancer Discov. 2015;5:806‐820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Corbett S, Courtiol A, Lummaa V, Moorad J, Stearns S. The transition to modernity and chronic disease: mismatch and natural selection. Nat Rev Genet. 2018;19:419‐430. [DOI] [PubMed] [Google Scholar]
  • 18. Segurel L, Wyman MJ, Przeworksi M. Determinants of mutation rate variation in the human germline. Annu Rev Genomics Hum Genet. 2014;15:45‐70. [DOI] [PubMed] [Google Scholar]
  • 19. Moorjani P, Amorim CEG, Arndt PF, Przeworski M. Variation in the molecular clock of primates. Proc Natl Acad Sci USA. 2016;113:10607‐10612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Harris K. Evidence for recent, population‐specific evolution of the genome mutation rate. Proc Natl Acad Sci USA. 2015;112:3439‐3444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Bae T, Tomasini L, Mariani J, et al. Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis. Science. 2018;359(6375):550‐555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Lynch M, Ackerman MS, Gout J‐F, et al. Genetic drift, selection and the evolution of the mutation rate. Nat Rev Genet. 2016;17:704‐714. [DOI] [PubMed] [Google Scholar]
  • 23. Kong A, Frigge ML, Masson G, et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature. 2012;488:471‐475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Scally A. The mutation rate in human evolution and demographic inference. Curr Opin Genet Devel. 2016;41:36‐43. [DOI] [PubMed] [Google Scholar]
  • 25. Milholland B, Dong X, Zhang L, Hao X, Suh Y, Vijg J. Differences between germline and somatic mutation rates in humans and mice. Nat Commun. 2017;8:15183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Ishikawa T, Masahito P, Nemoto N, Matsumoto J, Shima A. Spontaneous neurinoma in an African lungfish, Protopterus annectens, and DNA repair studies on normal and neoplastic tissues. J Natl Cancer Inst. 1986;77:521‐529. [PubMed] [Google Scholar]
  • 27. Roe WD, Alley MR, Cooper SM, Hazley L. Squamous cell carcinoma in a tuatara (Sphenodon punctatus). NZ Vet J. 2002;50:207‐210. [DOI] [PubMed] [Google Scholar]
  • 28. Ladds P. Pathology of Australian native wildlife. Collingwood: CSIRO Publishing; 2009. [Google Scholar]
  • 29. Hill AG, Dennis MM, Pyne M. Squamous cell carcinoma with hepatic metastasis in a saltwater crocodile (Crocodylus porosus). Aust Vet J. 2016;94:83‐86. [DOI] [PubMed] [Google Scholar]
  • 30. Ahmad AA, Dorrestein GM, Oh SJWY, Hsu CD. Multi‐organ metastasis of fibrolamellar hepatocellular carcinoma in a Malayan gharial (Tomistoma schlegelii). J Comp Path. 2017;157:80‐84. [DOI] [PubMed] [Google Scholar]
  • 31. Modiano JF, Breen M, Burnett RC, et al. Distinct B‐cell and T‐cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Res. 2005;65:5654‐5661. [DOI] [PubMed] [Google Scholar]
  • 32. Jenks S. Studying pet's cancers may yield health benefits for humans. J Natl Cancer Inst. 2015;107:1652‐8. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Medicine are provided here courtesy of Wiley

RESOURCES